Relationship between a low toxicity of the mutant A subunit of enterotoxigenic Escherichia coli enterotoxin and its strong adjuvant action

Immunology

Volumn 90, Issue 2, 1997, Pages 176-182

  Tsuji, T ^a   Yokochi, T ^b   Kamiya, H ^a   Kawamoto, Y ^a   Miyama, A ^a   Asano, Y ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; ESCHERICHIA COLI ENTEROTOXIN; HEMOCYANIN; IMMUNOLOGICAL ADJUVANT; MUTANT PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; OVALBUMIN;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; ESCHERICHIA COLI; MEASLES VIRUS; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; TOXICITY;

EID: 0031019336     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.00156.x     Document Type: Article

References (30)

1. HOLMGREN J. (1981) Actions of cholera toxin and the prevention and treatment of cholera. Nature 292, 413.
2. MEKALANOS J.J., SWARTZ D.J., PEARSON G.D.N., HARFORD N., GROYNE F. & DE WILDE M. (1983) Cholera toxin genes: Nucleotide sequence, deletion analysis and vaccine development. Nature 306, 551.
3. MCKENZIE S.J. & HALSEY J.F. (1984) Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response. J Immunol 133, 1818.
4. LYCKE N. & HOLMGREN J. (1986) Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 59, 301.
5. TAMURA S.-I., SAMEGAI Y., KURATA H., NAGAMINE T., AIZAWA C. & KURUTA T. (1988) Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit. Vaccine 6, 409.
6. VAN DER HEIJDEN P.J., BIANCHI A.T.J., DOL M., PALS J.W., STOK W. & BOKHOUT B.A. (1991) Manipulation of intestinal immune-responses against ovalbumin by cholera toxin and its B subunit in mice. Immunology 72, 89.
7. XU-AMANO J., KIYONO H., JACKSON R.J. et al. (1993) Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J Exp Med 178, 1309.
8. LYCKE N., TSUJI T. & HOLMGREN J. (1992) The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur J Immunol 22, 2277.
9. DOUCE G., TURCOTTE C., CROPLEY I. et al. (1995) Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc Natl Acad Sci USA 92, 1644.
10. DICKINSON B. & CLEMENTS J.D. (1995) Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect Immun 63, 1617.
11. DALLAS W.S., GILL D.M. & FALKOW S. (1979) Cistrons encoding Escherichia coli heat-labile toxin. J Bacteriol 139, 850.
12. OKUNO Y., UEDA S., KURIMURA T. et al. (1971) Studies on further attenuated live measles vaccine VII. Development and evaluation of CAM-70 measles virus vaccine. Biken J 14, 253.
13. ITO W., ISHIGURO H. & KUROSAWA Y. (1991) A general method for introducing a series of mutations into cloned DNA using the polymerase chain reaction. Gene 10, 67.
14. UESAKA Y., OTSUKA Y., LIN Z. et al. (1994) Simple method of purification of Excheriehia coli heat-labile enterotoxin and cholera toxin using immobilized galactose. Microbiol Pathog 16, 71.
15. TSUJI T., INOUE T., MIYAMA A., OKAMOTO K., HONDA T. & MIWATANI T. (1990) A single amino acid substitution in the A subunit of Escherichia coli enterotoxin results in a loss of its toxic activity. J Biol Chem 265, 22520.
16. Moss J., STANLEY S.J., VAUGHAN M. & TSUJI T. (1993) Interaction of ADP-ribosylation factor with Escherichia coli enterotoxin that contains an inactivating lysine 112 substitution. J Biol Chem 268, 6383.
17. LAEMMLI U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680.
18. NORRBY E. & OXMAN M.N. (1990) Measles virus. In: Virology (eds B.N. Fields & D.M. Knipe), 2nd edn. p. 1013. Raven Press Ltd., New York.
19. KRAMER S.M. & CREMER N.E. (1984) Biological activity of a monoclonal antibody to a Measles virus haemagglutinin epitope detected late in infection. J Gen Virol 65, 577.
20. GIRAUDON P. & WILD T.F. (1985) Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity. Virology 144, 46.
21. TAMURA S., ASAMURA H., ITO Y. et al. (1992) Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine. Eur J Immunol 22, 477.
22. CHEN K.S. & STROBER W. (1990) Cholera holotoxin and its B subunit enhance Peyer's patch B cell responses induced by orally administered influenza virus: Disproportionate cholera toxin enhancement of the IgA B cell response. Eur J Immunol 20, 433.
23. MUNOZ E., ZUBIAGA A.M., MERROW M., SAUTER N.P. & HUBER B.T. (1990) Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation. J Exp Med 172, 95.
24. LYCKE N., BROMANDER A.K., EKMAN L., KARLSSON U. & HOLMGRENN J. (1989) Cellular basis immunomodulation by cholera toxin in vitro with possible association to the adjuvant function in vivo. J Immunol 142, 20.
25. JACKSON R.J., FUJIHASHI K., XU-AMANO J., KIYONO H., ELSON C.O. & MCGHEE J.R. (1993) Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant. Infect Immun 61, 4272.
26. MCGHEE J.R., COSTE M., FUJIHASHI K. et al. (1994) Mechanism of action for the mucosal immunogen and adjuvant cholera toxin: practical application. In: The 30th Joint Conference U.S. Japan Cooperative Medical Science Program Cholera and Related Diarrhoeal Diseases Panel (eds K. Amako & R.L. Guerrant), pp. 161-165. Kyushu University Alumnus Hall, Fukuoka, Japan.
27. MCGHEE D.W., ELSON C.O. & MCGHEE J.R. (1993) Enhancing effect of cholera toxin on interleukin-6 secretion by IEC-6 intestinal epithelial cells: mode of action and augmenting effect of inflammatory cytokines. Infect Immun 61, 4637.
28. BROMANDER A., KJIERRULF M., HOLMGREN J. & LYCKE N. (1993) Cholera toxin enhances alloantigen presentation by cultured intestinal epitherial cells. Scand J Immunol 37, 452.
29. HOLMGREN J., LYCKE N. & CZERKINSKY C. (1993) Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine 11, 1179.
30. BROMANDER A., HOLMGREN J. & LYCKE N. (1991) Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro. J Immunol 146, 2908.